Emilia Antonucci Selected Research

Hemorrhage

4/2024	Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation.
12/2022	D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study.
7/2022	Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register.
1/2022	Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register.
7/2021	Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register.
3/2021	Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry.
3/2021	Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism.
1/2021	Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.
1/2021	Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
11/2020	Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emilia Antonucci Research Topics

Disease

31	Hemorrhage 04/2024 - 04/2003
25	Atrial Fibrillation 03/2024 - 01/2003
16	Stroke (Strokes) 03/2024 - 10/2005
16	Venous Thromboembolism 02/2024 - 04/2004
8	Thrombosis (Thrombus) 04/2024 - 12/2008
8	Acute Coronary Syndrome 03/2021 - 01/2006
6	Pulmonary Embolism 12/2022 - 02/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 02/2011 - 01/2006
5	Venous Thrombosis (Deep-Vein Thrombosis) 12/2022 - 12/2003
5	Hypertension (High Blood Pressure) 01/2022 - 10/2005
4	Thromboembolism 01/2022 - 12/2003
3	Neoplasms (Cancer) 05/2023 - 11/2019
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2018 - 03/2014
2	Overweight 01/2023 - 12/2019
2	COVID-19 07/2022 - 01/2022
2	Renal Insufficiency (Renal Failure) 01/2017 - 01/2015
2	Embolism (Embolus) 05/2012 - 10/2005
2	Thrombophilia 10/2010 - 09/2005
2	Myocardial Infarction 10/2007 - 11/2006
1	Hyperlipidemias (Hyperlipidemia) 04/2024
1	Wounds and Injuries (Trauma) 05/2023
1	Short Bowel Syndrome 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Uterine Hemorrhage (Uterine Bleeding) 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021
1	Chronic Renal Insufficiency 11/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019
1	Thrombocytopenia (Thrombopenia) 11/2019
1	Peripheral Arterial Disease 01/2017
1	Diabetes Mellitus 01/2017
1	Anemia 01/2017
1	Pulmonary Hypertension 07/2014
1	Heart Failure 10/2011
1	Transient Ischemic Attack 10/2011
1	Dyspnea (Shortness of Breath) 10/2010
1	Necrosis 10/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2007
1	Vascular Diseases (Vascular Disease) 03/2007
1	Dyslipidemias (Dyslipidemia) 06/2006
1	Left Ventricular Dysfunction 06/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005
1	Embolic Stroke 01/2003

Drug/Important Bio-Agent (IBA)

26	AnticoagulantsIBA 03/2024 - 01/2003
15	Vitamin K FDA Link 05/2021 - 08/2011
12	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 10/2005
7	fibrin fragment D (D-dimer)IBA 12/2022 - 09/2005
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2021 - 01/2017
3	CreatinineIBA 04/2024 - 01/2015
3	Clopidogrel (Plavix)FDA Link 03/2021 - 01/2006
3	Prothrombin (Factor II)IBA 01/2021 - 12/2003
3	Adenosine Diphosphate (ADP)IBA 02/2011 - 12/2008
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2007 - 01/2006
2	TicagrelorIBA 03/2021 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 03/2016
2	factor V LeidenIBA 01/2021 - 12/2003
2	FibrinIBA 07/2014 - 03/2013
1	Antiphospholipid AntibodiesIBA 04/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023
1	apixabanIBA 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	AcenocoumarolIBA 03/2021
1	GlycosaminoglycansIBA 03/2021
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 03/2021
1	Factor V (Coagulation Factor V)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2019
1	DiureticsIBA 11/2019
1	Prasugrel Hydrochloride FDA Link 01/2019
1	MetalsIBA 01/2017
1	Fibrinolysin FDA Link 07/2014
1	starlicideIBA 10/2010
1	prothrombin fragment 1IBA 10/2010
1	CoumarinsIBA 09/2009
1	CollagenIBA 12/2008
1	AntioxidantsIBA 03/2007
1	Fibrinogen (Factor I)FDA Link 06/2006
1	C-Reactive ProteinIBA 06/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2006
1	AntigensIBA 01/2006
1	HomocysteineIBA 10/2005

Therapy/Procedure

28	Therapeutics 04/2024 - 01/2003
4	Percutaneous Coronary Intervention 03/2021 - 11/2006
3	Secondary Prevention 01/2021 - 02/2009
2	Length of Stay 07/2022 - 01/2022
1	Duration of Therapy 02/2024
1	Home Parenteral Nutrition 01/2022
1	Hormonal Contraception 01/2021
1	Prostheses and Implants (Prosthesis) 09/2018
1	Drug-Eluting Stents 01/2017
1	Electric Countershock (Cardioversion) 05/2012
1	Thrombolytic Therapy 10/2011
1	Electrodes (Electrode) 06/2009
1	Stents 12/2008